FDA guidance seeks to better integrate patient priorities into drug development

Patient-centered drug development must start with an understanding of what patients feel is important about their condition and the attributes they’d like to see in medicines. A draft guidance FDA released Monday on Methods to Identify What is Important to Patients provides a road map for patients,

Read the full 474 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE